|
hepatocellular carcinoma |
9 |
|
berberine |
8 |
|
apoptosis |
6 |
|
autophagy |
6 |
|
bcl-2/beclin-1 |
6 |
|
medicine, chinese traditional |
6 |
|
mtor |
6 |
|
bile - chemistry |
5 |
|
cholagogues and choleretics - pharmacology - therapeutic use |
5 |
|
construct validation |
5 |
|
coptidis rhizoma aqueous extract |
5 |
|
gallbladder |
5 |
|
gardenia |
5 |
|
interprofessional attitudes |
5 |
|
interprofessional education |
5 |
|
iridoid glycosides |
5 |
|
iridoids |
5 |
|
microrna |
5 |
|
mir-21 |
5 |
|
mir-23a |
5 |
|
organotherapy |
5 |
|
alcoholic liver injury |
4 |
|
chinese medicines |
4 |
|
complementary and alternative medicines |
4 |
|
coptidis rhizome aqueous extract |
4 |
|
eukaryotic elongation factor 2 |
4 |
|
granulocytic‐myeloid‐derived suppressor cell‐like population |
4 |
|
gut microbiota |
4 |
|
herbal medicine |
4 |
|
medical sciences |
4 |
|
nascent protein synthesis |
4 |
|
oncology |
4 |
|
patent |
4 |
|
phytotherapy |
4 |
|
vascular endothelial growth factor |
4 |
|
anticancer drugs |
3 |
|
antimetastasis drugs |
3 |
|
antineoplastic agents, phytogenic - adverse effects - therapeutic use |
3 |
|
biomarker |
3 |
|
breast cancer |
3 |
|
chemotherapy |
3 |
|
diagnosis and therapy |
3 |
|
disease treating & preventing |
3 |
|
drug discovery |
3 |
|
herbal medicines |
3 |
|
liver neoplasms |
3 |
|
meta-analysis |
3 |
|
metabolomics |
3 |
|
molecular targets |
3 |
|
neoplasms - drug therapy |
3 |
|
plant extracts - adverse effects - therapeutic use |
3 |
|
recurrence |
3 |
|
review |
3 |
|
side effect |
3 |
|
traditional chinese medicine |
3 |
|
tumor angiogenesis |
3 |
|
vegf |
3 |
|
advanced glycation end products |
2 |
|
alanine transaminase - blood |
2 |
|
alternative therapy |
2 |
|
amp-activated protein kinases - metabolism |
2 |
|
ampk |
2 |
|
animals |
2 |
|
anti-liver fibrosis |
2 |
|
anti-oxidant agent |
2 |
|
apoptosis - drug effects |
2 |
|
aspartate aminotransferases - blood |
2 |
|
atg9b |
2 |
|
blood-retina-barrier breakdown |
2 |
|
cancer |
2 |
|
carbon tetrachloride |
2 |
|
carcinoma, hepatocellular - drug therapy - genetics - metabolism - pathology |
2 |
|
caspase 3 - metabolism |
2 |
|
chemotherapy induced nausea and vomiting |
2 |
|
chinese herbal medicine formula |
2 |
|
chronic liver damage |
2 |
|
colorecal cancer |
2 |
|
coptidis rhizoma |
2 |
|
diabetic retinopathy |
2 |
|
dna fragmentation - drug effects |
2 |
|
drug-induced liver injury - blood - drug therapy - pathology |
2 |
|
drugs, chinese herbal - analysis - therapeutic use |
2 |
|
er stress |
2 |
|
erk1/2 inhibition |
2 |
|
fangchinoline |
2 |
|
fatty liver |
2 |
|
gastrointestinal toxicity |
2 |
|
he-ying-qing-re formula |
2 |
|
hepatic carcinogenesis |
2 |
|
hepatocytes - drug effects - metabolism |
2 |
|
hepatoprotective effect |
2 |
|
huachansu capsules |
2 |
|
intracellular targets |
2 |
|
kegg pathway |
2 |
|
lipid metabolism |
2 |
|
lipolysis |
2 |
|
liver cancer |
2 |
|
liver cirrhosis - drug therapy |
2 |
|
liver neoplasms - drug therapy - genetics - metabolism - pathology |
2 |
|
male |
2 |
|
map kinase signaling system - drug effects |
2 |
|
natural products |
2 |
|
network pharmacology |
2 |
|
nuclear proteins - genetics - metabolism |
2 |
|
p53 |
2 |
|
patents as topic |
2 |
|
plant extracts - therapeutic use |
2 |
|
plants, medicinal |
2 |
|
rats |
2 |
|
rats, sprague-dawley |
2 |
|
retinal vasculature degeneration |
2 |
|
sestrin2 |
2 |
|
significant pathways |
2 |
|
traditional medicine |
2 |
|
tumor suppressor protein p53 - metabolism |
2 |
|
tumour-derived exosome |
2 |
|
yinchenhao decoction |
2 |
|
antrodia cinnamomea polysaccharide |
1 |
|
cancer metabolism |
1 |
|
immunosuppression |
1 |
|
invasion and metastasis |
1 |
|
oxidative stress |
1 |
|
proliferation and survival |
1 |
